ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2021

November 5-9, 2021. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
  • Abstract Number: 0643
    Tailored BP Connect Protocol with Implementation Support for Rheumatology Clinic Staff Exceeds Non-tailored Protocol at Improving Primary Care Referrals for Blood Pressure Follow-up
  • Abstract Number: 1877
    Takayasu Arteritis Patients with Tuberculosis Have Unique Clinical Characteristics
  • Abstract Number: 1728
    Takayasu’s Arteritis and Pregnancy: A Meta-analysis
  • Abstract Number: 0043
    Takinib Inhibits IL-1β-Induced Activation of Signal Transducer and Activator of Transcription 3 (STAT3) in Human Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 0189
    Tapering and Discontinuation of Background Therapies During the Transition to Rilonacept Monotherapy in RHAPSODY, a Phase 3 Clinical Trial of Rilonacept in Patients with Recurrent Pericarditis
  • Abstract Number: 0829
    Tapering and Withdrawal of Biologics or Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients with Inflammatory Arthritis: A Systematic Review and Meta-Analyses of Randomised Trials
  • Abstract Number: 0929
    Tapering of TNF Inhibitors in Patients with Axial Spondyloartritis – Can Flare Be Predicted?
  • Abstract Number: 1804
    Targeted Safety Analyses of Guselkumab (TREMFYA®): Long-term Results from Randomized Clinical Trials in Patients with Active Psoriatic Arthritis and Moderate to Severe Psoriasis
  • Abstract Number: 0544
    Targeting CD13/aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis
  • Abstract Number: 1440
    Targeting Endogenous Mesenchymal Stromal Cell Response to Interferong in Sjӧgren’s Syndrome
  • Abstract Number: 0559
    Targeting NNMT as a Novel Metabolic Approach to Treat Systemic Sclerosis
  • Abstract Number: 0054
    TCR Immune Profiling of Patients with Psoriatic Disease
  • Abstract Number: 1174
    Teaching and Reproducibility of a Pediatric Musculoskeletal Ultrasound Scoring System
  • Abstract Number: 1062
    Telemedicine Enriched Care Model to Optimize Care for Patients with Autoinflammatory Diseases
  • Abstract Number: 1606
    Telemedicine for Rheumatology Care During the COVID-19 Pandemic: Patient Perceptions and Preferences
  • Abstract Number: 0630
    Telemedicine in Rheumatology Care: A Systematic Review
  • Abstract Number: 1415
    Temporal Artery Biopsy Reports Can Be Accurately Classified by Artificial Intelligence
  • Abstract Number: 1053
    Temporal Trends and Geographic Variations of Premature Mortality Related to Musculoskeletal(MSK) and Connective Tissue Disorders in the United States: A 20-Year Analysis from WONDER Database
  • Abstract Number: 1060
    Temporal Trends of Arthropathies Related Mortality in the United States and Its Regional Variations from 1999-2018
  • Abstract Number: 0182
    Tenderness and Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis
  • Abstract Number: 0156
    Tenosynovitis Detected by Power Doppler Ultrasound: A Differential Feature of Patients with Seronegative Rheumatoid Arthritis
  • Abstract Number: 1716
    Teratogenic Medication Use Associated with Favorable Odds of Contraception Counseling in a Cohort of Women with Systemic Lupus Erythematosus at a Large Tertiary Academic Medical Center
  • Abstract Number: 1699
    The “ITIS” Diet Improves Fatigue in Patients with Rheumatoid Arthritis and Is Associated with Changes in Metabolome and Fecal Microbiome
  • Abstract Number: 0155
    The Additional Value of MRI in Diagnosis of Rheumatoid Arthritis in Undifferentiated Arthritis Patients
  • Abstract Number: 1088
    The Association Between Anti-Type Ⅱ Collagen Antibodies at the Time of Diagnosis and Recurrence in Relapsing Polychondritis
  • Abstract Number: 0223
    The Association of Clinical and Structural Knee Osteoarthritis with Physical Activity in the Middle-aged Population: The Netherlands Epidemiology of Obesity Study
  • Abstract Number: 0093
    The Association of General and Covid-19-Specific Stress with Changes in Patient-Reported Outcomes and Comorbidities
  • Abstract Number: 1118
    The Association of Hand OA with Paid an Unpaid Work Impairment and Related Costs: The Hand Osteoarthritis in Secondary Care Cohort
  • Abstract Number: 0871
    The Association of Hydroxychloroquine Dosing with Adverse Cardiovascular Events in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1059
    The Association of Pain and Sleep in Relation to Depressive Symptoms Among Older Adults with Arthritis
  • Abstract Number: 1036
    The Association of Patient Uncertainty with Mental Health in Systemic Autoimmune Rheumatic Diseases
  • Abstract Number: 0954
    The Association of Rituximab- vs. Cyclophosphamide-Based Remission Induction Strategies with Risk of End-Stage Renal Disease and Death in ANCA-Associated Vasculitis
  • Abstract Number: 0910
    The Association of TNF Inhibitor Use with Incident Hypertension in Ankylosing Spondylitis: Data from the PSOAS Cohort
  • Abstract Number: 1315
    The Best Cardiovascular Risk Algorithm to Predict the Presence of Carotid Plaque in Psoriatic Arthritis Patients
  • Abstract Number: 0557
    The Beta Secretase BACE1 Induces Systemic Sclerosis (SSc) Fibroblast Activation Through the Regulation of the Pro-Fibrotic Notch Signalling Pathway
  • Abstract Number: 1269
    The Burden of Systemic Lupus Erythematosus Patients in the United States – Evidence from the Medical Expenditure Panel Survey (2016-2018)
  • Abstract Number: 0594
    The Burden of Systemic Lupus in Five Distinct Racial and Ethnic Groups in Israel: A Population-based Study
  • Abstract Number: 1931
    The Burden of Thirty-day Readmission and Independent Predictors of Readmission in Patients with Systemic Lupus Erythematosus: A Nationwide Analysis
  • Abstract Number: 0346
    The CB-CAPillaryTM Test Kit: A Tool for Point-of-Care Assays to Measure Cell-Bound Complement Activation Products
  • Abstract Number: 0960
    The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA (STOP-JIA) Study: 24-Month Outcomes
  • Abstract Number: 0298
    The Clinical Phenotype of Isolated Ocular and Oral Dryness in Sjogren Syndrome, Fulfilling the 2016 ACR-EULAR Classification Criteria
  • Abstract Number: 0407
    The Clinical Role of T1 Mapping Cardiac Magnetic Resonance Imaging for Detecting Cardiac Involvement in the Early Stage of Systemic Sclerosis
  • Abstract Number: 0720
    The Clinical Significance of anti-PC4 and SFRS1 Interacting Protein 1 Antibody in Polymyositis and Dermatomyositis Patients
  • Abstract Number: 0537
    The Clinical, Oral Small Molecule IRAK4 Inhibitor, GS-5718, Improves Survival and Reduces Disease Pathologies by Modulating Multiple Inflammatory Endpoints in the Murine NZB/W Model of Spontaneous Lupus
  • Abstract Number: 1414
    The Current State of Expedited Referral Systems Incorporating Vasculitis Ultrasound for the Diagnosis of Giant Cell Arteritis in Rheumatology Practices in the United States
  • Abstract Number: 0481
    The Day-to-day Variability of Pain and the Relationship with Physical Activity in People with Knee Osteoarthritis: A Longitudinal, Observational Feasibility Study
  • Abstract Number: 0385
    The Diagnostic Utility of Serum interleukin-22 in Patients with Suspected Axial Spondyloarthritis
  • Abstract Number: 0494
    The Distribution of Social Deprivation, Distance to Care and Disease Burden in Rheumatoid Arthritis Patients in the United States
  • Abstract Number: 1801
    The Effect of Ixekizumab versus Adalimumab on Individual Components of the ACR Composite Score, with and Without Concomitant Methotrexate or Other Conventional Synthetic DMARDs at 52 Weeks in Patients with Psoriatic Arthritis
  • Abstract Number: 1246
    The Effect of Tocilizumab on miR-146a-5p and EMMPRIN/CD147 in Rheumatoid Arthritis Patients
  • Abstract Number: 0955
    The Effect of Treatment with the Complement C5a Receptor Inhibitor Avacopan on Health-Related Quality of Life in ANCA-Associated Vasculitis
  • Abstract Number: 0022
    The Effects of MAA-Modified and/or Citrullinated Proteins on Calcium Influx and Peptidyl Arginine Deiminase (PAD) Expression in Macrophage
  • Abstract Number: 0229
    The Effects of Self-efficacy on Fatigue and Pain Interference in Black Women with Systemic Lupus Erythematosus: The Role of Depression, Age, and Education
  • Abstract Number: 1708
    The Efficacy and Safety of Piclidenoson vs Methotrexate in Early Rheumatoid Arthritis: Phase 3 Randomized, Double-blind, Placebo-controlled Study
  • Abstract Number: 0121
    The Efficacy of Group Behavioral Activation versus Usual Treatment in Patients with Fibromyalgia and Major Depression
  • Abstract Number: 0536
    The EIF4 Translational Inhibitor Pateamine a Improves Immunological and Neurological Functions in BXSB.yaa Lupus Mice
  • Abstract Number: 1035
    The ELSA-Brasil Musculoskeletal Cohort (ELSA-Brasil MSK): Design, Implementation and Prevalence of Chronic Musculoskeletal Pain and Radiographic Knee Osteoarthritis at Baseline
  • Abstract Number: 0515
    The Extracellular Sulfatase-2 Inhibitor OKN-007 Abrogates TNF-α-induced Inflammatory Mediators in Human Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 1087
    The Humoral Immunity of mRNA-Based SARS-CoV2 Vaccine in Autoimmune Rheumatic Disease Patients Receiving Immunomodulators
  • Abstract Number: 1705
    The Impact of Age and Drug-Drug Interactions on QT Interval in Chronic Hydroxychloroquine Users
  • Abstract Number: 0673
    The Impact of Allopurinol on Blood Pressure and Renal Outcome in Gout Patients: A Retrospective Study
  • Abstract Number: 1075
    The Impact of an Integrated Care Management Program on Acute Care Use for Potentially Avoidable Conditions Among High-Risk Patients with SLE
  • Abstract Number: 1313
    The Impact of Comorbidities on Patients with Axial Spondyloarthritis: A Cluster Analysis
  • Abstract Number: 0798
    The Impact of Comorbidities on the Simple Disease Activity Index (SDAI) and Its Components over the First Year of Follow-up – an Analysis from the Canadian Early Arthritis Cohort (CATCH)
  • Abstract Number: 0485
    The Impact of COVID-19 on Rheumatology Trainee Health and Wellbeing: Results from the COVID-19 Global Rheumatology Alliance Trainee Survey
  • Abstract Number: 0296
    The Impact of Delayed Primary Sjögren’s Syndrome Diagnosis on Patient Outcomes: A Real-World Survey in the US
  • Abstract Number: 0232
    The Impact of Deucravacitinib on Health-Related Quality of Life Measured by the Short Form Health Survey 36-Item Questionnaire: Analysis of a Phase 2 Trial in Patients with Active PsA
  • Abstract Number: 0809
    The Impact of Flares on Clinical and Patient Reported Outcomes in Rheumatoid and Undifferentiated Arthritis Patients
  • Abstract Number: 1607
    The Impact of Health Literacy and Numeracy on COVID-19 Vaccine Hesitancy in SLE
  • Abstract Number: 0508
    The Impact of Macrophages Stimulated with Malondialdehyde-Acetaldehyde And/or Citrulline Modified Proteins on Fibroblasts Activation
  • Abstract Number: 0774
    The Impact of Patient/Provider Discordance on Changes on Mood and Behavior in Adolescents with Systemic Lupus Erythematosus
  • Abstract Number: 0238
    The Impact of Preeclampsia on Pregnancies and Infants of Women with Rheumatic Disease
  • Abstract Number: 1261
    The Impact of Remission and Low Disease Activity Attainment on Health-related Quality of Life in Two Phase III Clinical Trials of Belimumab in Systemic Lupus Erythematosus
  • Abstract Number: 1351
    The Impact of Skin Involvement and Depression on Patient Acceptable Symptom State in Patients with Psoriatic Arthritis and Psoriasis: Results from a Multinational Survey
  • Abstract Number: 0464
    The Impact of Timely Post-Discharge Follow-up on Readmission Risk Among Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1873
    The Importance of Lower Extremity Vein Wall Thickness in Patients with Behcet’s Syndrome
  • Abstract Number: 0336
    The Incremental Clinical Utility of a Multianalyte Assay Panel with Cell-Bound Complement Activation Products versus a Traditional ANA Testing Strategy for the Diagnosis and Treatment of SLE
  • Abstract Number: 0158
    The Influence of Age on the Prevalence of Inflammatory and Post-inflammatory MRI Lesions in the Sacroiliac Joints of Patients with and Without Axial Spondyloarthritis
  • Abstract Number: 1663
    The Influence of Comorbidity on Mortality in Patients with Rheumatoid Arthritis 1980-2015: A Longitudinal Population-based Study in Western Australia
  • Abstract Number: 1153
    The Influence of Companions on a Patient’s Decision to Transition to a Biosimilar: A Randomized Controlled Trial
  • Abstract Number: 1186
    The Kardashian Index of Rheumatology Program Directors: Comparing Scholarly Activity and Twitter Use of Rheumatology Fellowship Program Directors in the United States
  • Abstract Number: 0993
    The Mechanistic Basis of anti-CD6 as a Novel Form for the Treatment of Autoimmune Diseases and Cancer
  • Abstract Number: 0025
    The Modulatory Capacity of Galectin-3 on the Programmed Death-1 Signaling Axis in Rheumatoid Arthritis
  • Abstract Number: 1072
    The Multidisciplinary Approach with Patient Collaboration Improve the Clinical Effectiveness of the Intervention
  • Abstract Number: 0036
    The NAD+ Metabolism Is Altered in Rheumatoid Arthritis and Its Modulation with NAD+ Boosters Exhibits Key Anti-Inflammatory and Anti-Oxidant Effects
  • Abstract Number: 0571
    The National Incidence of Clinically Diagnosed Psoriatic Arthritis in Sweden 2014-2016
  • Abstract Number: 1226
    The Neuro-QOL Upper Extremity Function Scale: New Opportunities to More Reliably and Precisely Measure Self-reported Hand Function and Self-care Activities in People with RA
  • Abstract Number: 0348
    The New EULAR/ ACR 2019 SLE Classification Criteria: A Predictor of Long-term Outcomes
  • Abstract Number: 0217
    The OMERACT Knee Inflammation MRI Scoring System: Validation of Quantitative Methodologies and Tri-compartmental Overlays by Comparison with the MRI Osteoarthritis Knee Score
  • Abstract Number: 0759
    The Patient as Assessor of Disease Status: A Graphical Evaluation of Relations Between Patient-Reported Outcomes in Early Rheumatoid Arthritis
  • Abstract Number: 0760
    The Performance of RA Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis-Associated Interstitial Lung Disease in a Prospective Trial Using Pirfenidone in RA ILD (TRAIL1)
  • Abstract Number: 1748
    The Peroxisome Proliferator-Activated Receptor-γ (PPAR) Agonist Pioglitazone Improves Vascular and Metabolic Dysfunction in Patients with Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 0900
    The Phenomenon of Fused Sacroiliac Joints but Absent Syndesmophytes in Long Standing Ankylosing Spondylitis Patients: Data from a Prospectively Followed Cohort
  • Abstract Number: 0377
    The Prevalence of Inflammatory Back Pain and HLA-B27 in a Large Population-Based Cohort in the Netherlands
  • Abstract Number: 0820
    The PROPER Study: Results of the First 48-week Interim Analysis of a Pan-EU Real-world Study of SB5 Biosimilar Following Transition from Reference Adalimumab in Patients with Rheumatoid Arthritis, Axial Spondyloarthritis or Psoriatic Arthritis
  • Abstract Number: 0266
    The Psychosocial Impact of the COVID-19 Pandemic on the Rheumatology Patient Experience
  • Abstract Number: 1133
    The Relation of Serum Urate to Radiographic Knee Osteoarthritis in 2 Cohorts: The ELSA-Brasil MSK and the Original Cohort of the Framingham Heart Study
  • Abstract Number: 0519
    The Relationship of Genetics and Clinically Suspect Arthralgia in RA Development Assessed Using HC, CSA and RA Patients
  • Abstract Number: 1082
    The Rheumatology Workforce in Canada: Results of the Workforce and Wellness Survey
  • Abstract Number: 1941
    The Risk of Venous Thromboembolic Events in Patients with RA Aged ≥ 50 Years with ≥ 1 Cardiovascular Risk Factor: Results from a Phase 3b/4 Randomized Safety Study of Tofacitinib vs TNF Inhibitors
  • Abstract Number: 1778
    The Role of Cathepsin G in Joint Destruction in Patients with Psoriatic Arthritis
  • Abstract Number: 1869
    The Role of Faecal Calprotectin in IgA Vasculitis
  • Abstract Number: 0356
    The Role of Neutrophils in the Clinical Severity of Lupus Nephritis Patients with Concurrent Skin Disease
  • Abstract Number: 1254
    The Role of Regulatory T Cells (CD4+CD25+FOXP3) in Methotrexate Unresponsiveness in a Cohort of Naive Rheumatoid Arthritis Patients
  • Abstract Number: 0114
    The Safety Profile of SARS-CoV-2 Vaccines Among Patients with Immune-Mediated Rheumatic Diseases
  • Abstract Number: 0996
    The Stimulator of Interferon Genes (STING) Protects from Bone Loss Through Regulation of Tonic and Induced Type I Interferon Pathways
  • Abstract Number: 0558
    The Systemic Sclerosis (SSc) Risk Gene A20 (TNFAIP3) and Its Repressor DREAM Determine Susceptibility to Fibrosis
  • Abstract Number: 0591
    The Temporal Association Between Hospital Admissions, Disease-modifying Anti-rheumatic Drugs Usage and Direct Health Care Costs in Rheumatoid Arthritis Patients
  • Abstract Number: 1798
    The Transition to Psoriatic Arthritis: What Factors Predict a Shorter Transition from Psoriasis to Psoriatic Arthritis?
  • Abstract Number: 0096
    The True Prevalence of SARS-CoV-2 Infection in an Italian Cohort of Patients with Inflammatory Arthritis: A Seroepidemiological Study
  • Abstract Number: 1366
    The Use of Lipid-Lowering Agents in Systemic Sclerosis: Is There a Relationship with Prevalence of Digital Ulcers and Overall Survival?
  • Abstract Number: 1946
    Therapeutic Drug Monitoring Compared to Standard Infliximab Therapy in Patients with Immune-mediated Inflammatory Diseases: A Randomized Controlled Trial
  • Abstract Number: 0738
    Therapeutic Effects of Oral Chinese Patent Medicine on Knee Osteoarthritis
  • Abstract Number: 0535
    Therapeutic Efficacy of a Biomimetic ALXR Agonist in Murine Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 0471
    Therapeutic Efficacy of BT-104, an Oral LANCL2 Agonist, for the Treatment of Systemic Lupus Erythematosus
  • Abstract Number: 1147
    Therapeutic Inertia and Low Patient Compliance: Major Contributors to Low Treatment Rates in Patients with Osteoporosis with Clinical Vertebral Compression Fractures
  • Abstract Number: 0140
    Therapeutic Management and Clinical Remission in a Specialized Dermatological-Rheumatological Center for Patients with Psoriasis and Psoriatic Arthritis
  • Abstract Number: 1558
    Therapy Based Outcomes in Patients with Multisystem Inflammatory Syndrome in Children: A Single Center Study
  • Abstract Number: 1860
    Three Distinct Transcriptional Profiles of Monocytes Correlate with Disease Activity in SSc Patients
  • Abstract Number: 0247
    Three-year Effectiveness in Patients with JIA Initiating Abatacept: Results from the PRCSG/PRINTO JIA Real-World Registry
  • Abstract Number: 0081
    Thrombin Generation Assay and Lupus Anticoagulant Identify Different Populations of Patients with Antiphospholipid Antibodies
  • Abstract Number: 1819
    Tildrakizumab Efficacy and Safety in Patients with Psoriatic Arthritis by Metabolic Syndrome Status
  • Abstract Number: 0645
    Time Burden of QTc Screening for HCQ Users at a Single VA Rheumatology Clinic
  • Abstract Number: 0055
    Time Course of Intestinal Permeability and Intestinal Inflammation in Rat Adjuvant-induced Arthritis
  • Abstract Number: 0721
    Timed Function Tests as Measures of Disease Activity and Functional Outcome in Inflammatory Myositis
  • Abstract Number: 0641
    Title: EHR-Supported Staff Protocol Improves Smoking Cessation in a Diverse Rheumatology Clinic: Updated Results of Quit Connect Dissemination
  • Abstract Number: 0087
    TNF Inhibitors and the Risk of Adverse COVID-19 Outcomes in Patients with Immune-Mediated Inflammatory Disease: Pooled Data from Three Global Registries
  • Abstract Number: 0477
    TNX-102 SL (Sublingual Cyclobenzaprine) for the Treatment of Fibromyalgia in the RELIEF Study: Positive Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Efficacy and Safety Trial
  • Abstract Number: 1834
    To What Extent Do Clinical Features of PsA Predict Achievement of Minimal Disease Activity at Week 24: A Post Hoc Analysis of the Phase III Clinical Trial Program of Guselkumab in a Bio-naïve Patient Population
  • Abstract Number: 0193
    Tocilizumab for the Treatment of Familial Mediterranean Fever – a Randomized, Double Blind, Placebo-controlled Phase II Study
  • Abstract Number: 1878
    Tocilizumab in Caucasian Patients with Takayasu Arteritis: Multicenter Study of 54 Patients
  • Abstract Number: 1413
    Tocilizumab in Combination with 8 Weeks of Prednisone for Giant Cell Arteritis
  • Abstract Number: 0507
    Tocilizumab in Patients with New Onset Polymyalgia Rheumatica (PMR-SPARE) – a Phase 2/3 Randomized Controlled Trial
  • Abstract Number: 1704
    Tofacitinib in Rheumatoid Arthritis: Is There a Correlation Between a Rapid Analgesic Effect and a Decrease in Activity After 3 and 6 Months?
  • Abstract Number: 0732
    Topical Rofecoxib for OA of the Knee
  • Abstract Number: 0727
    Total Joint Replacements in Three Phase 3 Studies of Tanezumab in Patients with Osteoarthritis
  • Abstract Number: 0452
    Total-Body 18F-FDG PET/CT Imaging: A Tool for Diagnosis and Quantifying Inflammatory Burden of Psoriatic Arthritis
  • Abstract Number: 0517
    TPMT and NUDT15 Genotype and Azathioprine Myelotoxicity in Patients with Inflammatory Conditions: Results from Real-World Clinical Practice
  • Abstract Number: 0893
    Trajectories of Depressive Symptoms in Systemic Lupus Erythematosus over 7 Years
  • Abstract Number: 0526
    Transcriptional Factor Profiling Denotes Specific Synovial Macrophage Heterogeneity
  • Abstract Number: 0942
    Transcriptional Regulation of Synovial Macrophages in the Aging Joint
  • Abstract Number: 0523
    Transcriptional Subsetting of SLE Patient Cohorts Based on Metabolic Pathway Activity
  • Abstract Number: 0506
    Transcriptomic Changes Induced by Mavrilimumab versus Tocilizumab in ex-vivo Cultured Arteries from Patients with Giant-cell Arteritis
  • Abstract Number: 1112
    Transient Elastography (Fibroscan) as a Non-Invasive Method for Detecting Amyloid Deposition in Transplanted Kidneys in Patients with AA Amyloidosis
  • Abstract Number: 1111
    Transient Elastography (fibroscan); As a New Non-invasive Diagnostic Method for Detecting Hepatic Involvement of Amyloidosis
  • Abstract Number: 0783
    Transmission Disequilibrium Testing Meets Next Generation Sequencing: Applying TDT to Whole Genome Data in Childhood-Onset Systemic Lupus Erythematosus
  • Abstract Number: 1446
    Trauma Is Associated with Flares in Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 1235
    Treatment Effect of Baricitinib on Fatigue: Mediation Analysis Results from Two Phase 3 Trials
  • Abstract Number: 0139
    Treatment of Ankylosing Spondylitis by Primary Care Physicians and Rheumatologists in an Academic Health System: A Retrospective Study
  • Abstract Number: 1408
    Treatment of Giant Cell Arteritis in the ARTESER Multicenter Study of 1675 Patients
  • Abstract Number: 1397
    Treatment of Giant Cell Arteritis with Tocilizumab: A Retrospective Cohort Study of 119 Patients
  • Abstract Number: 1736
    Treatment of Lupus Nephritis with Belimumab Is Associated with Reduction in Urinary CD23
  • Abstract Number: 1816
    Treatment of Non-biologic-DMARD-IR PsA Patients with Upadacitinib or Adalimumab Results in the Modulation of Distinct Functional Pathways: Proteomics Analysis of a Phase 3 Study
  • Abstract Number: 0207
    Treatment of Ocular Sarcoidosis: Study of 65 Patients of a Series of 384 Patients from a Single University Hospital
  • Abstract Number: 1263
    Treatment of Pediatric Lupus Is Associated with Significant Re-Organization of B Cell Chromatin
  • Abstract Number: 1749
    Treatment Patterns in Latin American Patients with Lupus Nephritis over a 20-year Period
  • Abstract Number: 0463
    Treatment Persistence Among Medicare Beneficiaries with Seropositive Rheumatoid Arthritis Initiating Biologic or Targeted Synthetic DMARDs
  • Abstract Number: 1339
    Treatment Persistence Was Similar at 3 Years in Patients with Psoriatic Arthritis Treated with Ustekinumab (STELARA®) or a Tumor Necrosis Factor Inhibitor in a Prospective Real-World Study
  • Abstract Number: 0550
    Treatment Regimens and Outcomes in Systemic Sclerosis-associated Pulmonary Arterial Hypertension
  • Abstract Number: 0795
    Treatment Response and Several Patient-reported Outcomes Are Early Determinants of Future Self-efficacy in Patients with Rheumatoid Arthritis
  • Abstract Number: 0138
    Treatment with Adalimumab in Patients with Chronic Inflammatory Rheumatic Diseases: A Study of Treatment Trajectories on a Patient Level in Clinical Practice
  • Abstract Number: 1465
    Trends in Adverse Pregnancy Outcomes Among Women with Systemic Sclerosis in the United States
  • Abstract Number: 0339
    Trends in Disparity by Age, Sex and Race for Systemic Lupus Erythematosus Patients
  • Abstract Number: 1598
    Trends in Medication Interruptions and Associations with Disease Flares During a Public Health Crisis: Longitudinal Data from Patients with Autoimmune Rheumatic Diseases During the COVID-19 Pandemic
  • Abstract Number: 0221
    Trunk Movement Compensation Is Associated with Physical Performance Measures and Fatigue Deficits in Hip Osteoarthritis
  • Abstract Number: 0451
    Tumor Necrosis Factor Inhibitors Show a Delayed Effect on Radiographic Sacroiliitis Progression in Patients with Early Axial Spondyloarthritis: 10-Year Results from the German Spondyloarthritis Inception Cohort
  • Abstract Number: 0511
    Tumor Necrosis Factor-α Modulates Endothelial-to-mesenchymal Transition and Increases Protein Tyrosine Phosphatase 1B
  • Abstract Number: 1706
    Twenty-four-week Follow-up of a Randomized Controlled First-in-Human Trial of the Safety and Efficacy of Neurostimulation with a Miniaturized Vagus Nerve Stimulation Device in Patients with Multidrug-Refractory Rheumatoid Arthritis
  • Abstract Number: 1286
    Twenty-Year Trends in Systemic Lupus Erythematosus All–Cause Mortality in Mexico: A Nationwide Health Registry
  • Abstract Number: 1487
    Type I Interferon Modulates Langerhans Cell ADAM17 in Lupus to Contribute to Photosensitivity
Jump to:  View All • a b c d e f g h i j k l m n o p q r s [t] u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences